ロード中...
BH3 profiling discriminates the anti-apoptotic status of 5-fluorouracil-resistant colon cancer cells
5-Fluorouracil (5-FU) is a cytotoxic anticancer drug commonly used for patients with advanced colon cancer. This drug effectively reduces the size of tumors to a certain degree; however, cancer cells can gradually acquire resistance, resulting in disease progression. To identify the mechanism of 5-F...
保存先:
| 出版年: | Oncol Rep |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6826312/ https://ncbi.nlm.nih.gov/pubmed/31638265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2019.7373 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|